REPEAT/APO Health Begins Trading Publicly Today.Business Editors & Health/Medical Writers BIOWIRE2K REPEATING OCEANSIDE, N.Y.--(BW HealthWire)--June 13, 2001 APO apo- 1 A prefix indicating a protein component in a conjugated molecule–eg, apoferritin, apolipoprotein, see there 2 Apolipoprotein, see there Health (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: APOA APOA Apolipoprotein A APOA Albuquerque Police Officers Association ) announces it has completed its reverse merger with InternetFinancialCorp.com (OTC BB: IFAN IFAN Institut Fondamental d'afrique Noire IFAN Institut Français d'Afrique Noire (French Institute of Black Africa) IFAN International Federation of Standards Users ) and will begin immediately trading on the Nasdaq OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. today under the symbol APOA. APO Health is a multi-faceted distributor of medical, dental and veterinary supplies. These products include protective garments such as disposable isolation gowns, facemasks and gauzes as well as latex gloves, needles, syringes, pharmaceuticals, instruments, and health and beauty aids. Through its three catalogs, word of mouth and direct marketing, the company has established a position in four divisions of the health industry: veterinary supplies, medical supplies, dental supplies and pharmaceuticals. APO Health offers its customers significant savings on over 8,0000 disposable products. "We are very excited to be trading publicly," said Dr. Jan Stahl, President of APO Health. "This gives us the ability to expand the scope of our original business plan into possible mergers and acquisitions, and other opportunities not previously available to us." As a private company, APO Health did approximately $7 million in revenue last quarter, which ended March 31, 2001. The company completed year 2000 with approximately $30 million in sales, which ended September 30, 2000. This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995) that involve risks and uncertainties. A number of important factors could cause the Company's actual results, performance of achievements for fiscal 2001 and beyond to differ materially from that expressed in such forward-looking statements. These factors are set forth in the Company's filings with the Securities and Exchange Commission and include, without limitation, material chances in economic conditions, competition in the Company's industry, operating losses, uncertainties relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the developing market for new media, changing technologies, seasonality, ability to collect amounts owed to the Company, failure to accurately estimate the time and resources necessary for the performance of services, ability to maintain and expand name recognition, the Company's dependence on key clients and projects and key personnel, costs and uncertainties relating to closing offices, potential adverse effects of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , and the ability of the Company to maintain the listing on the Over The Counter Bulletin Board stock exchange or another principal trading exchange. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion